HANXBIO-B 03378Hong Kong Stock Exchange

28.8200.91%( +0.260 )
Closed: Oct 9 · Delayed · Hong Kong Stock Exchange
HANXBIO-B (03378) Company Profile - Company Info, Industry & Management - cibo

Company Information

Company Name
Hanx Biopharmaceuticals (Wuhan) Co., Ltd.
Market
HKEX Main Board
Listing Date
2025-12-23
Industry
Innovative Drugs & Biologics
Fiscal Year End
Dec 31
ISIN
CNE100007C34

Industry

Innovative Drugs & Biologics 0.02%
124 stocks in this industry
Down 52 Up 57
Industry RankingsValue (HKD)Rank
Net Profit (Last FY)-153.63M69/125
ROE (Last FY)-18.78%76/117

Change is the 2026-10-09 close against the previous close; the industry change is the equal-weighted average of its stocks. Sub-industry classification is maintained by cibo. Last FY is each company's latest annual report. Net profit is profit attributable to owners of the parent; ROE = net profit / closing equity attributable to owners. Non-HKD statements are converted at ECB reference rates.

Management

NamePosition
张发明 Executive Director
李其翔 Executive Director
刘敏 Executive Director
肖婕妤 Executive Director
李健 Non-Executive Director
毕红钢 Independent Non-Executive Director
陈奇峰 Independent Non-Executive Director
王世雄 Independent Non-Executive Director
张琼光 Independent Non-Executive Director

Board list from the HKEXnews "List of Directors and their Role and Function", as of 2026-02-08.

About this page

This page shows HANXBIO-B (03378) company information, related securities, the price change distribution and in-industry rankings within its sub-industry, and the board of directors. Quotes come from HKEX Daily Quotations, financial metrics from each company's latest annual report, and the director list from HKEXnews.